These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3131749

  • 1. The effects of antagonists of vasoactive intestinal peptide on nonadrenergic noncholinergic inhibitory responses in feline airways.
    Thompson DC, Altiere RJ, Diamond L.
    Peptides; 1988; 9(2):443-7. PubMed ID: 3131749
    [Abstract] [Full Text] [Related]

  • 2. Effects of vasoactive intestinal polypeptide antagonists on cholinergic neurotransmission in dog and cat trachea.
    Xie ZQ, Hirose T, Hakoda H, Ito Y.
    Br J Pharmacol; 1991 Dec; 104(4):938-44. PubMed ID: 1667294
    [Abstract] [Full Text] [Related]

  • 3. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
    Pozo D, Montilla ML, Guerrero JM, Calvo JR.
    Eur J Pharmacol; 1997 Mar 05; 321(3):379-86. PubMed ID: 9085051
    [Abstract] [Full Text] [Related]

  • 4. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
    Waelbroeck M, Robberecht P, Coy DH, Camus JC, De Neef P, Christophe J.
    Endocrinology; 1985 Jun 05; 116(6):2643-9. PubMed ID: 2859987
    [Abstract] [Full Text] [Related]

  • 5. The action of vasoactive intestinal peptide antagonists on peptidergic modulation of the squid Schwann cell.
    Evans PD, Villegas J.
    J Exp Biol; 1988 Sep 05; 138():259-69. PubMed ID: 3142961
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
    Rodríguez-Pena MS, Guijarro LG, Prieto JC.
    Eur J Pharmacol; 1991 Nov 13; 208(3):207-12. PubMed ID: 1663044
    [Abstract] [Full Text] [Related]

  • 7. Lack of effect of vasoactive intestinal peptide antagonists on blood flow in the rat thyroid.
    Michalkiewicz M, Huffman LJ, Hedge GA.
    Peptides; 1991 Nov 13; 12(6):1181-6. PubMed ID: 1815206
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP antagonists in dog and cat trachea.
    Hakoda H, Ito Y.
    J Physiol; 1990 Sep 13; 428():133-54. PubMed ID: 2172520
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum.
    Grider JR, Rivier JR.
    J Pharmacol Exp Ther; 1990 May 13; 253(2):738-42. PubMed ID: 2110976
    [Abstract] [Full Text] [Related]

  • 11. The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle.
    Ellis JL, Farmer SG.
    Br J Pharmacol; 1989 Mar 13; 96(3):513-20. PubMed ID: 2720290
    [Abstract] [Full Text] [Related]

  • 12. Evidence for vasoactive intestinal peptide as a mediator of non-adrenergic non-cholinergic neurotransmission in the trachea.
    Venugopalan CS, Holmes EP, O'Malley NA.
    J Auton Pharmacol; 1990 Oct 13; 10(5):297-304. PubMed ID: 1964680
    [Abstract] [Full Text] [Related]

  • 13. An analogue of growth hormone releasing factor (GRF), (Ac-Try1, D-Phe2)-GRF-(1-29), specifically antagonizes the facilitation of the flexor reflex induced by intrathecal vasoactive intestinal peptide in rat spinal cord.
    Xu XJ, Wiesenfeld-Hallin Z.
    Neuropeptides; 1991 Mar 13; 18(3):129-35. PubMed ID: 2067598
    [Abstract] [Full Text] [Related]

  • 14. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S, Rattan S.
    J Pharmacol Exp Ther; 1993 Jul 13; 266(1):392-9. PubMed ID: 8392560
    [Abstract] [Full Text] [Related]

  • 15. Role of vasoactive intestinal polypeptide in the internal anal sphincter relaxation of the opossum.
    Nurko S, Rattan S.
    J Clin Invest; 1988 Apr 13; 81(4):1146-53. PubMed ID: 3127424
    [Abstract] [Full Text] [Related]

  • 16. VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.
    Aizawa H, Inoue H, Shigyo M, Takata S, Koto H, Matsumoto K, Hara N.
    Lung; 1994 Apr 13; 172(3):159-67. PubMed ID: 8201830
    [Abstract] [Full Text] [Related]

  • 17. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
    Laburthe M, Couvineau A, Rouyer-Fessard C.
    Mol Pharmacol; 1986 Jan 13; 29(1):23-7. PubMed ID: 3003561
    [Abstract] [Full Text] [Related]

  • 18. Effect of alpha-chymotrypsin on the nonadrenergic noncholinergic inhibitory system in cat airways.
    Altiere RJ, Diamond L.
    Eur J Pharmacol; 1985 Aug 07; 114(1):75-8. PubMed ID: 4043222
    [Abstract] [Full Text] [Related]

  • 19. Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine artery but do not antagonize VIP-induced relaxations.
    Morris JL, Murphy R.
    Eur J Pharmacol; 1989 Mar 21; 162(2):375-9. PubMed ID: 2542061
    [Abstract] [Full Text] [Related]

  • 20. Nonadrenergic noncholinergic neurotransmitter of feline trachealis: VIP or nitric oxide?
    Fisher JT, Anderson JW, Waldron MA.
    J Appl Physiol (1985); 1993 Jan 21; 74(1):31-9. PubMed ID: 7680336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.